SCHEMBL9103795

SCHEMBL9103795

CC(C)CC(C(=O)Nc1ccccn1)N1C(=O)C(=O)c2cc(Cl)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.46
GCK P35557 2/20 0.46
RAB9A P51151 4/20 0.45
ALDH1A1 P00352 3/20 0.45
NPC1 O15118 3/20 0.45
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
KCNMA1 Q12791 1/20 0.43
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 1/20 0.41
GRIK1 P39086 1/20 0.41
RIPK1 Q13546 1/20 0.41
MEN1 O00255 2/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
MITF O75030 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9104263 0.93 FFAR2 (0.47) FFAR2GCKRAB9AALDH1A1NPC1
SCHEMBL9108285 0.89 GCK (0.46) GCKRAB9AALDH1A1NPC1USP2
SCHEMBL9109212 0.89 GCK (0.46) GCKRAB9AALDH1A1NPC1USP2
SCHEMBL9108958 0.88 GCK (0.53) GCKRAB9AALDH1A1NPC1USP2
SCHEMBL9107161 0.88 FFAR2 (0.47) FFAR2GCKRAB9AALDH1A1NPC1
SCHEMBL9908110 0.88 FFAR2 (0.47) FFAR2GCKRAB9AALDH1A1NPC1
SCHEMBL9106739 0.87 GCK (0.44) GCKRAB9AALDH1A1NPC1POLB
SCHEMBL9107525 0.84 CHRM5 (0.46) GCKRAB9AALDH1A1NPC1
SCHEMBL9908106 0.83 GCK (0.55) GCKS1PR1S1PR3KCNMA1
SCHEMBL9104481 0.83 GCK (0.55) GCKS1PR1S1PR3KCNMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT FFAR2 627/4885GCK 488/4885RAB9A 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.